As we enter the 2019 labeling landscape—with changing regulations and slashed submission timelines—producing labels with 100% accuracy is proving to be increasingly complex and load-bearing for clinical supply teams. In the months to come, here are a few key topics that we are keeping an eye on.
Bryan Clayton, Vice President, Strategic Solutions, YPrime recently presented a webinar on IRT technology. This article recaps the discussion on IRT terminology, SDLC methodologies and how different approaches can save time, risk and cost.
As companies are looking to reduce their supplier base and shifting towards more strategic relationships with key suppliers to achieve economies of scale, learn how contract suppliers can benefit from developing strategic partnerships with other vendors and operating as one entity.
With such abundant clinical trial opportunities in China, and such a wide range of innovative eClinical technology available to take advantage of them, there has never been a better time to be a clinical researcher.
The industry is seeing continued regulatory guidelines aimed at moving sponsors and technology companies to modernize clinical studies. In addition to that a common challenge is a breakdown in communication throughout the study lifecycle.. Kevin Landells, Vice President of Project Management at Cenduit, shares his insights on an eClinical technology provider consistently achieve client satisfaction.
Highly variable demand cycles, further de-risking the business, and increasingly inexperienced interactive response technology (IRT) stakeholders are a few of the crucial, data-driven challenges facing studies. Learn how industrializing OpEx drives quality patient outcomes and provides a means for continuous improvement.
Jennifer Aquino, Chief Operating Officer at Cenduit recently had the opportunity to visit with several clients and opinion leaders on a year-end “listening tour,” to discuss their issues and goals for 2019 and beyond. Read what they had to say regarding the industry’s challenges and opportunities.
Can you really improve the economics and safety of clinical studies by choosing expedience over expertise? The answer is a decisive “no,” Read insights from Cenduit on their experiences with sponsors that needed then to rescue a study due to problems with their original IRT selection.
Dr. Joan Meyer, Covance Executive Director of Strategy & Planning for Inflammation, Infectious Diseases and General Medicine, discusses her team’s efforts to better understand patients’ opinions about inflammatory bowel disease trials and develop patient-centered clinical strategies to improve study recruitment.
While ultra-low temperatures are the current state-of-the-art solution for biospecimen storage, ambient storage is an interesting option and could be superior in certain limited situations. For many types of samples, it’s possible that we will always have to use ultra-low temperatures for long-term storage. For other sample types, such as DNA and RNA, there are alternative solutions.
|
|
|
|
|
|
|
|
|